Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
연구 개요
This study is researching a particular group of experimental drugs administered for a short period in the treatment of participants with Lupus Nephritis (LN). The main aim of the current study is to see how safe and tolerable the study drugs are in a long-term follow-up. This is a main study, called an umbrella study, which includes several independent smaller sub-studies. Each of these smaller main sub-studies tests different drugs at the same time, all aimed at treating LN. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is in the blood at different times * Whether the body makes antibodies against the study drug (which could make the drug less effective or could lead to side effects)
- 스폰서
- 리드: 리제네론
- 적응증
- Lupus Nephritis (LN)
- 중재
- Vonsetamig, Odronextamab
- 목표 등록
- 90명
- 시작일
- 2025-12-22
- 완료(예정)
- 2029-09-09
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.